The Journal of community and supportive oncology
-
J Community Support Oncol · Nov 2014
Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy.
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose-limiting toxicity of cytostatics. With improved survival among cancer patients, CIPN may have a major impact on quality of life (QoL) of cancer survivors. ⋯ After a median follow-up of 6.5 months after cessation of therapy with oxaliplatin or taxanes, CIPN is common and leads to impairment in patient QoL. More research is needed to assess the impact of neurotoxicity on QoL.